Literature DB >> 27873569

Establishing a Standard of Care for Deep Brain Stimulation Centers in Canada.

Michel Panisset1, Marina Picillo2, Nicolas Jodoin1, Yu-Yan Poon2, Alejandro Valencia-Mizrachi2, Alfonso Fasano2, Renato Munhoz2, Christopher R Honey3.   

Abstract

During the "DBS Canada Day" symposium held in Toronto July 4-5, 2014, the scientific committee invited experts to share their knowledge regarding deep brain stimulation (DBS) management of movement disorders in three domains: (1) the programming algorithms, (2) the necessary team to run a neurosurgery program, and (3) the appropriate scales to better define in a more comprehensive fashion the effect of the brain surgery. Each presentation was followed by an open discussion, and this article reports on the conclusions of this meeting on these three questions. Concerning programming, the role of the pulse width and the switching off of the stimulation at night for thalamic stimulation for the control of tremor have been discussed. The algorithms proposed in the literature for programming in Parkinson's disease (PD) need validation. In dystonia, the use of monopolar vs bipolar parameters, the use of low vs high frequencies and the use of smaller versus larger pulse widths all need to be examined properly. Concerning the necessary team to run a neurosurgical program, recommendations will follow the suggestions for standardized outcome measures. Regarding the outcome measures for DBS in PD, investigations need to focus on the non-motor aspects of PD. Identifying which nonmotor symptoms respond to DBS would allow a better screening before and satisfaction postoperatively. There is an important need for more data to determine the optimal programming protocol and the standard measures that should be performed routinely by all centers.

Entities:  

Keywords:  Parkinson’s disease; dystonia; deep brain stimulation; essential tremor; programming; tremor

Mesh:

Year:  2016        PMID: 27873569     DOI: 10.1017/cjn.2016.409

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  2 in total

1.  Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease.

Authors:  Marina Picillo; Onanong Phokaewvarangkul; Yu-Yan Poon; Cameron C McIntyre; Sinem Balta Beylergil; Renato P Munhoz; Suneil K Kalia; Mojgan Hodaie; Andres M Lozano; Alfonso Fasano
Journal:  Mov Disord       Date:  2020-11-09       Impact factor: 10.338

2.  Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach.

Authors:  Naomi P Visanji; Mahdi Ghani; Eric Yu; Erfan Ghani Kakhki; Christine Sato; Danielle Moreno; Taline Naranian; Yu-Yan Poon; Maryam Abdollahi; Maryam Naghibzadeh; Rajasumi Rajalingam; Andres M Lozano; Suneil K Kalia; Mojgan Hodaie; Melanie Cohn; Marta Statucka; Alexandre Boutet; Gavin J B Elias; Jürgen Germann; Renato Munhoz; Anthony E Lang; Ziv Gan-Or; Ekaterina Rogaeva; Alfonso Fasano
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.